Previous small cohort studies have proven that in anti-synthetase syndrome or inflammatory myopathy, anti-SS-A antibody-positive individuals develop more severe ILD including more extensive pulmonary fibrosis and decreased LF. The gene discussed is TRIM21; the disease is interstitial lung disease.